Transformative Healthcare Instrument 2026

About

The Transformative Healthcare Instrument 2026 offers European healthcare startups funding between €300,000 and €500,000 to advance product development and commercialisation strategies while addressing unmet clinical needs, with specific eligibility criteria focused on company size and investment history.

Benefits

• 💰Funding
  Request between €300,000 and €500,000 in funding; maximum 50% of total project costs covered
• 📈Commercialisation support
  Strengthen commercialisation strategies and prepare for fundraising
• 🧪Product development
  Advance product development addressing unmet clinical needs

Eligibility Criteria

• Private companies
• Micro, Small and Medium-sized enterprises (SMEs)
• At least 4 full-time equivalent employees
• Minimum total equity investment of 2,000,000 EUR within the previous 36 months
• Specific Innovation Maturity Levels depending on industry focus

Participation Commitments

• Secure remaining 50% co-funding from other sources.
• Participate in scheduled sessions for guidance.

Target Region

Europe

Target Sector

Biotech, Medtech, Digital Health, AI, Biomarkers, Diagnostics